XENETIC BIOSCIENCES, INC. Increase (Decrease) in Interest Payable, Net
XENETIC BIOSCIENCES, INC. (XBIO) reported Increase (Decrease) in Interest Payable, Net of $5.70 thousand for the 3-month period ending 2013-11-30, per its 10-Q filed 2014-01-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2014-01-10
- XENETIC BIOSCIENCES, INC. increase (decrease) in interest payable, net for the quarter ending 2013-11-30 was $5.70K, a 78.14% increase year-over-year.
- XENETIC BIOSCIENCES, INC. increase (decrease) in interest payable, net for the quarter ending 2013-08-31 was $3.23K, a 0.00% change year-over-year.
- XENETIC BIOSCIENCES, INC. increase (decrease) in interest payable, net for the quarter ending 2013-05-31 was $3.23K, a 0.00% change year-over-year.
- XENETIC BIOSCIENCES, INC. increase (decrease) in interest payable, net for the quarter ending 2013-02-28 was $3.16K, a 1.06% decline year-over-year.
- XENETIC BIOSCIENCES, INC. increase (decrease) in interest payable, net for fiscal 2013 was $12.82K, a 1.45% decline from fiscal 2012.
- XENETIC BIOSCIENCES, INC. increase (decrease) in interest payable, net for fiscal 2012 was $13.01K.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 7 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 10 month | Increase (Decrease) in Interest Payable, Net 12 month | Increase (Decrease) in Interest Payable, Net 19 month | Increase (Decrease) in Interest Payable, Net 22 month |
|---|---|---|---|---|---|---|---|---|
| 2013-11-30 | $5.70K 10-Q · filed 2014-01-10 | $8.93K derived: sum of 2 quarters · filed 2014-01-10 | $12.16K derived: sum of 3 quarters · filed 2014-01-10 | $15.32K derived: sum of 4 quarters · filed 2014-01-10 | ||||
| 2013-08-31 | $3.23K derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-27 | $6.46K derived: sum of 2 quarters · filed 2013-11-27 | $9.63K derived: sum of 3 quarters · filed 2013-11-27 | $12.82K 10-K · filed 2013-11-27 | ||||
| 2013-05-31 | $3.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-07-17 | $6.39K derived: sum of 2 quarters · filed 2013-07-17 | $9.59K 10-Q · filed 2013-07-17 | $12.82K derived: sum of 4 quarters · filed 2014-01-10 | $23.15K 10-Q · filed 2013-07-17 | |||
| 2013-02-28 | $3.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-04-22 | $6.36K 10-Q · filed 2013-04-22 | $9.59K derived: sum of 3 quarters · filed 2014-01-10 | $12.82K derived: sum of 4 quarters · filed 2014-01-10 | $19.92K 10-Q · filed 2013-04-22 | |||
| 2012-11-30 | $3.20K 10-Q · filed 2014-01-10 | $6.43K derived: sum of 2 quarters · filed 2014-01-10 | $9.66K derived: sum of 3 quarters · filed 2014-01-10 | $12.86K derived: sum of 4 quarters · filed 2014-01-10 | ||||
| 2012-08-31 | $3.23K derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-27 | $6.46K derived: sum of 2 quarters · filed 2013-11-27 | $9.66K derived: sum of 3 quarters · filed 2013-11-27 | $13.01K 10-K · filed 2013-11-27 | ||||
| 2012-05-31 | $3.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-07-17 | $6.43K derived: sum of 2 quarters · filed 2013-07-17 | $9.78K 10-Q · filed 2013-07-17 | $10.33K 10-Q · filed 2012-07-16 | ||||
| 2012-02-29 | $3.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-04-22 | $6.55K 10-Q · filed 2013-04-22 | $7.10K 10-Q · filed 2012-04-24 | |||||
| 2011-11-30 | $3.35K 10-Q · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |